We are currently working on a new site and apologise for any functionality issues you may experience. To be the first to view our new site and updated product lists please sign up to our newsletter.
IPG have been asked to undertake GMP audits in China through the services of their collection of PRC based auditors.
IPG has been active auditing workshops in China since 2000 with over 350 such inspections coving API’s, Dosage forms of all types from sterile biologics to solid dose tablets, laboratories, warehouses, supply chains and GDP operations. Usually, IPG will charge a fixed rate for such one site inspection be it one day or five days covering 3 hours travelling with accommodation presented at a fixed rate and extra travel costs if more than 3 hours travel by car.
For more information please click here.
ICE Pharma Group (IPG) is a generic pharmaceutical company with its own Marketing Authorisations (MAs) and experienced operational teams who can manage the manufacturing process through to a final product release into the European market. IPG is MHRA approved, holds GMP and GDP certification, and has approvals to import both APIs and Finished Drugs from outside Europe. We have Manufacturing and Importation Authorisation (MIA) and Wholesale Distribution Authorisation (WDA) for import and sales of products in Europe.
IPG was founded in the UK in 1999 to source API’s and intermediates. The company achieved early success in introducing new Indian and Chinese manufacturers to the generics sector. Eventually moving up the value chain, IPG has built extensive experience through a range of projects and has built a network of highly skilled industry experts in manufacturing generic products, owning licenses and providing support services to new MAH’s and more. IPG has also helped launch numerous new generics onto the world markets; providing its customers and partners with technical and commercial expertise, critical to successful project implementation.